Bedaquiline
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1849 publications
Pan-TB regimens: too good to be true?
Journal: Expert review of anti-infective therapy
Published: September 07, 2026
Guidelines for off-label use of anti-tuberculosis drugs
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: September 07, 2026
Effectiveness of Bedaquiline-, Delamanid- and Linezolid-Containing Regimens in Improving Treatment Outcomes Among Pediatric and Adolescents With Drug-Resistant Tuberculosis in the Country of Georgia.
Journal: The Pediatric infectious disease journal
Published: August 28, 2026
No phenotypic resistance observed for most group-3 and -4 variants in Mycobacterium tuberculosis genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context.
Journal: Microbiology spectrum
Published: July 28, 2026
Pharmacokinetics and safety of TBAJ-587, a novel antimycobacterial diarylquinoline, in healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: July 28, 2026
Editorial: Tuberculosis transmission: a battle between the host and the pathogen.
Journal: Frontiers in microbiology
Published: July 23, 2026
Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in Mycobacterium tuberculosis using TM4::GeNL reporter mycobacteriophages.
Journal: Microbiology spectrum
Published: July 15, 2026
The Mycobacterial cyt-bc1:aac3 Oxidase as a Drug Target: Activities of Arylvinylpiperazine Amides and Aminoquinazolines against Mycobacterium ulcerans.
Journal: Journal of medicinal chemistry
Published: July 14, 2026
In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: July 13, 2026
Adverse Drug Reactions Associated With Longer All-Oral MDR/XDR-TB Regimens: Prospective Pharmacovigilance Evidence From a High-Burden Tertiary Care Setting in North India.
Journal: The Annals of pharmacotherapy
Published: July 13, 2026
Last Updated: 09/26/2026